Nikhil Vad
机构: Postdoctoral Fellow, University of Cincinnati
每年引用次数
引用次数
引用: 545
H-指数: 11
I10-指数 : 11
出版物: 47
Phenolic compounds as antimelanoma agents: A selective melanoma targeted prodrug approach
Nikhil Madhav Vad
2009
SC-31RATIONAL DESIGN OF A PI3-KINASE/mTOR INHIBITOR CYTOTOXIC TO BRAIN CANCER STEM CELLS UNDER HYPOXIA
N. Vad , S. Jagannathan , K. Sumita , M. Abdel-Malek
Neuro-oncology 16
1
2014
TM-03THE HSP90 INHIBITOR GANETESPIB IS AN EFFECTIVE THERAPY FOR GLIOBLASTOMA THAT BLOCKS EGFR-DRIVEN TUMOR GROWTH
J. Driscoll , N. Vad , S. Jagannathan
Neuro-oncology 16
1
2014
Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice
Nikhil M Vad , Shashi K Kudugunti , Daniel Graber , Nathan Bailey
International journal of oncology 35 ( 1) 193 -204
16
2009
ER stress, unfolded protein response, and autophagy are pro-survival responses to fenretinide+ safingol treatment in GBM cells
Nikhil M Vad , Dong Wang , Barry J Maurer
Cancer Research 76 ( 14_Supplement) 4656 -4656
2016
Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: An enzyme directed prodrug approach
Nikhil M Vad , Prabodh K Kandala , Sanjay K Srivastava , Majid Y Moridani
Chemico-Biological Interactions 183 ( 3) 462 -471
9
2010
PHARMACOKINETICS, PHARMACODYNAMICS AND DRUG METABOLISM: Metabolic Bioactivation and Toxicity of Ethyl 4-Hydroxybenzoate in Human SK-MEL-28 Melanoma Cells
Nikhil M VAD , Imam H SHAIK , Reza MEHVAR , Majid Y MORIDANI
Journal of pharmaceutical sciences 97 ( 5) 1934 -1945
2008
Curcumin induced toxicity towards human SK-MEL-28 melanoma cells
Nikhil Vad , Majid Moridani
Cancer Research 67 3966 -3966
2007
Abstract #660: In-vitro and in-vivo investigation of Caffeic acid Phenyl Ethyl Ester (CAPE) prodrug as an anti-melanoma agent
Shashi Kudugunti , Nikhil Vad , Majid Moridani ,
Cancer Research 69 660 -660
2009
Biochemical mechanism of acetaminophen (APAP) toxicity in human melanocytic melanoma cell lines: a tyrosinase produrg activation approach
Garret Yount , Nikhil Vad , Jon Weidanz , Tiffany Nguyen
Cancer Research 68 1289 -1289
2008
Ethyl 4-hydroxybenzoate toxicity towards human SK-MEL-28 melanoma cell line involves mitochondrial toxicity, intracellular GSH depletion, quinone and reactive oxygen species formation
Nikhil Vad , Majid Moridani , Imam Shaik , Reza Mehvar
Cancer Research 67 3968 -3968
2007
Structure-activity relationship of phenolic analogues as anti-melanoma agents: a drug metabolism drug design approach
Nikhil Vad , Majid Y. Moridani , Shana Benpoorat
Cancer Research 66 265 -265
2006
Abstract A18: MicroRNA-29b replacement inhibits proteasomes and disrupts the aggresome-autophagy pathway to enhance the antimyeloma benefit of bortezomib.
Sajjeev Jagannathan , Nikhil Vad , Mohamed Abdel-Malek , Ehsan Malek
Clinical Cancer Research 21
2015
Correlation of Non-Coding RNA Expression with Response to Proteasome Inhibitors in Multiple Myeloma
Ehsan Malek , Tahir Latif , Anil Goud Jegga , Sajjeev Jagannathan
Blood 124 ( 21) 3415 -3415
2014
Novel Therapeutic Strategies to Target Protein Quality Control Compartments in Multiple Myeloma
Mohamed A.Y. Abdel Malek , Sajjeev Jagannathan , Ehsan Malek , Nikhil Vad
Blood 124 ( 21) 3433 -3433
2014
Metformin Suppresses the GRP78-Dependent Delivery of Aggresomes to Autophagosomes to Enhance the Anti-Myeloma Benefit of Proteasome Inhibition
Sajjeev Jagannathan , Nikhil Vad , Mohamed A.Y. Abdel Malek , Ehsan Malek
Blood 124 ( 21) 433 -433
2014
Microrna-29b Targets PSME4 to Inhibit Proteasome Activity and Prevent the Delivery of Aggresomes to Autophagosomes for Anti-Myeloma Benefit
Sajjeev Jagannathan , Nikhil Vad , Mohamed A.Y. Abdel Malek , Ehsan Malek
Blood 124 ( 21) 4703 -4703
2014
469 Cooperation between checkpoint inhibitors targeting the PD-1/PD-L1 axis and ATRC-101, a novel clinical-stage candidate for the treatment of solid tissue malignancies
Amy Manning-Bog , Jeff DeFalco , Alexander Scholz , Iraz Aydin
Journal for ImmunoTherapy of Cancer 8
2020
689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
Yvonne Leung , Nikhil Vad , Anne Ye , Daniel Santos
Journal for ImmunoTherapy of Cancer 8
2020
Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101
Alexander Scholz , Jeff DeFalco , Yvonne Leung , Iraz T Aydin
Proceedings of the National Academy of Sciences 119 ( 19) e2123483119
1
2022